These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice. Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291 [TBL] [Abstract][Full Text] [Related]
28. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi. Dolan MC; Zeidner NS; Gabitzsch E; Dietrich G; Borchert JN; Poché RM; Piesman J Am J Trop Med Hyg; 2008 May; 78(5):803-5. PubMed ID: 18458316 [TBL] [Abstract][Full Text] [Related]
29. Searching for autoimmunity in "antibiotic-refractory" Lyme arthritis. Stricker RB; Johnson L Mol Immunol; 2008 Jun; 45(11):3023-4. PubMed ID: 18395260 [TBL] [Abstract][Full Text] [Related]
30. Novel antibiotic-resistance markers in pGK12-derived vectors for Borrelia burgdorferi. Sartakova ML; Dobrikova EY; Terekhova DA; Devis R; Bugrysheva JV; Morozova OV; Godfrey HP; Cabello FC Gene; 2003 Jan; 303():131-7. PubMed ID: 12559574 [TBL] [Abstract][Full Text] [Related]
31. Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells. Brown CR; Blaho VA; Loiacono CM Infect Immun; 2004 Sep; 72(9):4956-65. PubMed ID: 15321987 [TBL] [Abstract][Full Text] [Related]
32. Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition. Wagh D; Pothineni VR; Inayathullah M; Liu S; Kim KM; Rajadas J Drug Des Devel Ther; 2015; 9():805-16. PubMed ID: 25709405 [TBL] [Abstract][Full Text] [Related]
33. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. Ates L; Hanssen-Hübner C; Norris DE; Richter D; Kraiczy P; Hunfeld KP Ticks Tick Borne Dis; 2010 Mar; 1(1):30-4. PubMed ID: 21771509 [TBL] [Abstract][Full Text] [Related]
34. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine. Brorson O; Brorson SH Int Microbiol; 2002 Mar; 5(1):25-31. PubMed ID: 12102233 [TBL] [Abstract][Full Text] [Related]
35. Eucaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Brouqui P; Badiaga S; Raoult D Antimicrob Agents Chemother; 1996 Jun; 40(6):1552-4. PubMed ID: 8726038 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo susceptibility of Borrelia burgdorferi. Mursic VP; Wilske B; Schierz G; Holmburger M; Süss E Eur J Clin Microbiol; 1987 Aug; 6(4):424-6. PubMed ID: 3665899 [TBL] [Abstract][Full Text] [Related]
37. Protection of phagocytized bacteria against antibiotics. A new method for the evaluation of neutrophil granulocyte functions. Solberg CO Acta Med Scand; 1972 May; 191(5):383-7. PubMed ID: 4482853 [No Abstract] [Full Text] [Related]
38. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Steere AC; Angelis SM Arthritis Rheum; 2006 Oct; 54(10):3079-86. PubMed ID: 17009226 [No Abstract] [Full Text] [Related]
39. Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A. Codolo G; Bossi F; Durigutto P; Bella CD; Fischetti F; Amedei A; Tedesco F; D'Elios S; Cimmino M; Micheletti A; Cassatella MA; D'Elios MM; de Bernard M Arthritis Rheum; 2013 May; 65(5):1232-42. PubMed ID: 23371320 [TBL] [Abstract][Full Text] [Related]
40. Anaplasma phagocytophilum-infected neutrophils enhance transmigration of Borrelia burgdorferi across the human blood brain barrier in vitro. Nyarko E; Grab DJ; Dumler JS Int J Parasitol; 2006 May; 36(5):601-5. PubMed ID: 16600247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]